Form 4: Castle Biosciences Director Exercises Stock Options
SEC Form 4 Filing
Director Rodney Cotton exercised stock options on March 26, 2025, acquiring 5,329 shares of Castle Biosciences common stock.
Summary
- On March 26, 2025, Rodney Cotton, a director of Castle Biosciences, exercised restricted stock units (RSUs) to acquire 5,329 shares of common stock.
- The RSUs are part of a grant of 15,988 RSUs awarded on March 26, 2024, which vest in three equal annual installments starting March 26, 2025.
- Following the transaction, Cotton directly owns 10,659 derivative securities.
Sentiment
Score: 5
Explanation: This is a neutral event. It simply reflects the exercise of previously granted stock options, which is a routine part of executive compensation.
Industry Context
This is a standard Form 4 filing, reflecting insider transactions. These filings are routinely monitored by investors to gauge management's sentiment and confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 03/26/2024 | Reporting Person was granted 15,988 RSUs which vest in three equal annual installments beginning on March 26, 2025. |
| 03/26/2025 | Director Rodney Cotton exercised stock options to acquire 5,329 shares of Castle Biosciences common stock. |
| 03/28/2025 | Date of signature of the report. |
Keywords
Form 4, insider trading, stock options, Rodney Cotton, Castle Biosciences, CSTL, RSU
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.